Wen Chu
Angel Investor @ GWC Innovator Fund
Beijing, China
Wen Chu is a seed investor at GWC Innovator Fund in Beijing focused on Internet and Artificial Intelligence. Wen Chu is the CEO and Founder of GWC.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 22%
Last updated:
For AI agents: llms.txt
Industries Wen Chu invests in
Stages Wen Chu invests in
Countries Wen Chu invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Internet 3 (33%)
- Artificial Intelligence 2 (22%)
- EdTech 1 (11%)
- GovTech 1 (11%)
- Robotics 1 (11%)
Stage
- Seed 2 (22%)
- Series A 2 (22%)
- Venture - Series Unknown 2 (22%)
- Series C 1 (11%)
- Series E 1 (11%)
Country
- China 4 (44%)
- United States 3 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Visabot is an AI-powered solution for streamlining U.S. visa process. Visabot helps complete visa applications and provides other immigration-related services. | Seed / Aug 01, 2017 | ||
| MAMA+ aims to help more mothers "become a better mother," for the benefit of family and society as a concept, is committed to "serve for mothers"; the same time, Internet technology and family relations research as a dual-driven, brought together many passionate technical talent. Researchers who can feel empathy with theirmothers are all motivated by their mothers' needs and insist on using their strength to make their feelings come true so as to realize more value for their mothers. | Series C / Apr 07, 2017 | ||
| Visabot is an AI-powered solution for streamlining U.S. visa process. Visabot helps complete visa applications and provides other immigration-related services. | $475K / Seed / Feb 21, 2017 | ||
| Blue Tide Data | Venture - Series Unknown / Jan 01, 2017 | ||
| Intarcia Therapeutics is a biopharmaceutical company that develops therapies for diseases that require long-term chronic treatment. It offers DUROS, a drug delivery platform that stabilizes and delivers therapeutic proteins and peptides. Intarcia Therapeutics' products include OMEGA DUROS, an interferon delivery device for treating HepatitisC and ITCA 650, a delivery device that provides type 2 diabetes patients with long-term steady state dosing of an incretin mimetic therapy. Additionally, it develops programs for treating obesity. David Franklin, James M. Ahlers, and Thomas Alessi founded BioMedicines in 1997 that became Intarcia Therapeutics in September 2004. Its headquarters is in Hayward in California with an additional office in Mountain View in California. | $206M / Series E / Dec 29, 2016 | ||
| Hangzhou Extreme Wood Technology Co., Ltd. is a technology innovation company specializing in artificial intelligence and key technologies of robots. It is committed to the application and development of autonomous driving technology and intelligent control technology in the field of industrial wheeled robots. The first product is a smart parkingrobot based on autonomous driving technology. | Venture - Series Unknown / Oct 01, 2016 | ||
| Xiaopeng Motors is an electric vehicle and technology company that designs and manufactures intelligent mobility solutions. | $40M / Series A / Mar 01, 2016 | ||
| DayDayUp is a business community that connects Chinese and global innovators. | Seed / Oct 01, 2015 | ||
XPENG motors
|
Series A |
Co-Investors
About GWC Innovator Fund
Their newly launched GWC Innovator Fund is a venture fund focused exclusively on investing in global innovators that are improving the world. Some of their recent investments include 3D Robotics in the US, Goqii in India, DayDayUp in China and Qraved in Indonesia. G-Startup Worldwide (https://angel.co/g-startup-worldwide) is theirglobal startup competition held around the world to find the most innovative, early stage startups, invest $1,000,000 in them, support them with a global network and enable them to change the world.
GWC Innovator Fund Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Barrett Parkman
Managing Partner
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Wen Chu invest in?
Wen Chu invests primarily in Internet, Artificial Intelligence and EdTech startups, most often at Seed and Series A stage. Most of the 9 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Wen Chu?
Public channels for Wen Chu include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Wen Chu last invest?
The most recent investment recorded for Wen Chu closed in Aug 2017. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
